Enhanced SARS-CoV-2 breakthrough infections in patients with hematologic and solid cancers due to Omicron.
Mair MJ, Mitterer M, Gattinger P, Berger JM, Trutschnig W, Bathke AC, Gansterer M, Berghoff AS, Laengle S, Gottmann L, Buratti T, Haslacher H, Lamm WW, Raderer M, Tobudic S, Fuereder T, Valenta R, Fong D, Preusser M.
Mair MJ, et al. Among authors: gansterer m.
Cancer Cell. 2022 May 9;40(5):444-446. doi: 10.1016/j.ccell.2022.04.003. Epub 2022 Apr 12.
Cancer Cell. 2022.
PMID: 35429443
Free PMC article.
No abstract available.